Motor-assisted Cycling and FES Cycling for Postprandial Glucose in Diabetic Patients With ADL Disability
Effects of Motor-assisted Cycling and Functional Electrical Stimulation Cycling on Postprandial Glucose in Type 2 Diabetic Patients With Activities of Daily Living Disability
1 other identifier
interventional
9
1 country
1
Brief Summary
Exercise has been the cornerstone of diabetes management. However, many diabetic patients have ADL disabilities and experience substantial difficulty in performing usual exercises, such as brisk walking and upright cycling. There is an urgent need to provide alternative exercise modalities for diabetic patients with ADL disabilities. In this study, investigators will investigate the effects on the glucose of three exercise modalities, including motor-assisted cycling (i.e., cycling on a motor-driven bike) and functional electrical stimulation (FES) cycling, during which the investigators will use electrical current to facilitate cycling movements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 20, 2019
CompletedFirst Submitted
Initial submission to the registry
June 19, 2019
CompletedFirst Posted
Study publicly available on registry
June 21, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 15, 2019
CompletedNovember 15, 2019
November 1, 2019
9 months
June 19, 2019
November 14, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postprandial glucose AUC
The glucose will be measured using CGM during the 2-hour postprandial period.
Study Arms (3)
Control
NO INTERVENTIONParticipants remain seated for 2 hours after the intake of a standardized breakfast.
Motor-assisted cycling
EXPERIMENTALParticipants will perform 3 bouts of motor-assisted cycling, each bout lasting 10 minutes, after the intake of a standardized breakfast.
FES cycling
EXPERIMENTALParticipants will perform 3 bouts of FES cycling, each bout lasting 10 minutes, after the intake of a standardized breakfast.
Interventions
Participants will perform the motor-assisted cycling exercise using a physical therapy bike (RECK; Betzenweiler, Germany). Participants will perform 3×10-min bouts of motor-assisted cycling at the highest tolerable cadence. Before each bout, participants will perform 1-2 minutes of motor-assisted cycling at 5-10 rpm as a warm-up.
The testing procedures will be identical to that in the motor-assisted cycling visit except for the exercise type. Participants will wear FES cuffs on the upper and lower legs, bilaterally. . The FES cycling will be performed on the motor-assisted bike using the wearable FES equipment. The purpose of motor-assisted cycling is to provide constant cadence. The Bioness L300 Plus system (Bioness, Valencia, CA) will be worn on the upper and lower legs to stimulates the quadriceps and dorsiflexors muscles during the motor-driven cycling exercise. An embedded gyroscope of the cuff can detect the motion of the lower leg so that the electrical stimulations will be generated at appropriate timing to activate leg muscles during the cycling exercise.
Eligibility Criteria
You may qualify if:
- Age above 60 years.
- Physician-diagnosed type 2 diabetes.
- ADL disability (self-reported).
You may not qualify if:
- Fasting glucose ≥ 250 mg/dL.
- Symptomatic hypoglycemic events in the past three months.
- Insulin injection or infusion
- Systolic blood pressure ≥ 160 mmHg OR Diastolic blood pressure ≥ 100 mmHg
- Diagnosis of NYHA class I-IV heart failure
- Myocardial infarction in the past 6 months
- Recent or current angina, shortness of breath, or other symptoms suggestive of heart failure
- Diagnosed Cancer
- Unable to consent due to impaired cognitive function
- Bone fracture, joint dislocation, or joint stiffness
- Local skin disorders at the FES cuff area or CGM sensor area
- Implantable electronic or metallic devices, such as cardioverter defibrillator and pacemaker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Brookdale Senior Living Central Chandler
Chandler, Arizona, 85224, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
June 19, 2019
First Posted
June 21, 2019
Study Start
February 20, 2019
Primary Completion
November 15, 2019
Study Completion
November 15, 2019
Last Updated
November 15, 2019
Record last verified: 2019-11
Data Sharing
- IPD Sharing
- Will not share